02/09/2015 - 1:47pm

Daiichi Sankyo on Monday announced that its Savaysa (edoxaban) tablets are now available in pharmacies across the United States. The drug was granted approval from the Food and Drug Administration on Jan. 8 and is used to reduce the risk of stroke and systemic embolism in patients who have a non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis and pulmonary embolism, the company said.

02/09/2015 - 1:26pm

Under new bipartisan legislation, seniors would have more convenient access to discounted or "preferred" co-pays for prescription drugs at their pharmacy of choice.

02/06/2015 - 3:13pm

A new, potentially far-reaching program to encourage individuals to take better charge of their own health is taking shape in the United Kingdom. And given the increasingly globalized marketplace, the emergence of Walgreens Boots Alliance as an international pharmacy powerhouse and the ongoing struggle by U.S. pharmacies to gain provider status and reimbursement for a growing menu of patient-care services, that campaign could spark or help inform similar efforts on this side of the Atlantic.

 

02/06/2015 - 12:50pm

GlaxoSmithKline officially launched its Flonase allergy relief onto nonprescription shelves.

02/06/2015 - 9:32am

Prestige Brands will be resuming healthcare professional marketing programs in support of its Monistat vaginal treatments.

02/05/2015 - 2:16pm

In light of the renewed discussions on the efficacy and safety of childhood vaccinations, The American Pharmacists Association issued a statement on the important role childhood and lifespan vaccinations play in protecting personal and public health.

02/05/2015 - 1:51pm

On the one-year anniversary of its decision to stop tobacco sales, CVS Health released new data showing that its messages about the importance of quitting smoking for good is resonating.

02/05/2015 - 1:07pm

Merck earlier this week announced that Belsomra (suvorexant) is now available at pharmacies in the United States for the treatment of insomnia.

02/05/2015 - 10:57am

Acura Pharmaceuticals on Thursday announced the launch of their second pseudoephedrine product, Nexafed Sinus Pressure + Pain.